Disclosure: We earn commissions on purchases made through our links. This never influences our scores. Editorial policy

Methylene Blue
Bottom line
In our scoring, Methylene Blue rates weak evidence: the human evidence is thin for memory and cognition. Our top-scored product is Methylene Blue Drops 1% Pharmaceutical Grade (2-pack) (80/100), about $0.33 a day at a clinical dose of Nootropic 'microdoses' are ~5-15 mg/day. Bottom line: treat any benefit as unproven. This is our opinion, not medical advice; talk to your clinician before starting.
Methylene blue is a genuinely unusual entry: a 150-year-old synthetic dye that is also an FDA-approved drug and, lately, a viral biohacker supplement.
- Evidence
- Weak Evidence
- Category
- Cognitive & Nootropics
- Best form
- ONLY USP / pharmaceutical grade with a published COA - never aquarium or industrial grade
- Effective dose
- Nootropic 'microdoses' are ~5-15 mg/day
- Lab tested
- 4 of 5 products
- Category
- Cognitive & Nootropics
- Best form
- ONLY USP / pharmaceutical grade with a published COA - never aquarium or industrial grade
- Effective dose
- Nootropic 'microdoses' are ~5-15 mg/day
- Lab tested
- 4 of 5 products
Key takeaways
- →Two hard safety rules come before any benefit: use ONLY USP/pharmaceutical grade (never aquarium/industrial dye), and NEVER combine it with antidepressants (serotonin-syndrome risk, FDA-warned).
- →Also contraindicated in G6PD deficiency and pregnancy. Turns urine and tongue blue (harmless).
- →The nootropic evidence is thin: one small human study showed a modest memory gain - but at ~280 mg, about 20x a typical 'microdose'. Real pharmacology, weak human proof for the everyday use.
- →The dose-response is U-shaped - low may help, high does harm. If used at all: pharmaceutical grade, low dose (5-15 mg), and not while on antidepressants.
What Is Methylene Blue?
Methylene blue is a genuinely unusual entry: a 150-year-old synthetic dye that is also an FDA-approved drug and, lately, a viral biohacker supplement. It has real pharmacology and real, serious risks, but thin human evidence for the nootropic use it is sold for. Two safety rules dominate this page and should shape any decision before benefits even enter the conversation: use only pharmaceutical-grade product, and never combine it with antidepressants. Get either of those wrong and this goes from "interesting experiment" to "medical emergency."
Rule one is grade. Only USP or pharmaceutical-grade methylene blue is fit to swallow. The exact same molecule is sold as cheap aquarium and industrial dye that can contain heavy metals and other contaminants - those are made to color fabric or treat fish tanks, not for human use, and must never be ingested. A trustworthy product states USP or pharmaceutical grade and can show a third-party certificate of analysis screening for heavy metals and contaminants. If a seller cannot show that, treat the product as unknown.
Rule two is the drug interaction, and it is a hard stop, not a caution. Methylene blue is a potent inhibitor of the enzyme MAO-A, the same mechanism as MAOI antidepressants. Combined with SSRIs, SNRIs, other antidepressants, tramadol, triptans, or other serotonergic drugs, it can trigger serotonin syndrome - a potentially fatal reaction. The FDA has warned about this, and it is why anyone on an antidepressant should simply not use methylene blue. It is also contraindicated in G6PD deficiency (risk of red-blood-cell breakdown) and in pregnancy.
On benefits, honesty matters. The mechanism is real: at low doses methylene blue acts as an "alternative electron carrier" that can support mitochondrial energy production under stress (Rojas 2012; Gonzalez-Lima 2014). But the human evidence for making you smarter or sharper is essentially one small brain-imaging study that found a modest memory improvement (Rodriguez 2016) - and, crucially, that study used a single dose of about 280 mg, roughly twenty times the 5-15 mg "microdose" most supplements are sold at. So the marquee human result does not actually validate the low doses people take. And the dose-response is U-shaped: low doses may help, high doses do harm and can even cause the very blood problem the drug is used to treat. More is not better here; more is dangerous. Bottom line: real drug, real risks, genuinely thin evidence for the everyday nootropic use - proceed only with pharmaceutical-grade product, only if you are not on antidepressants, and only at low doses.
Does It Work? The Evidence
How A-F grades workMethylene Blue earns a Weak Evidence rating - human evidence is thin across its claimed uses, the best-supported being enhances memory and cognition (nootropic) and supports mitochondrial energy production (grade C). Each claim is graded individually below.
Can cause serotonin syndrome with antidepressants
Ramsay et al. 2007 (Br J Pharmacol): methylene blue potently inhibits MAO-A; case reports and reviews (Zuschlag 2018; McMillan 2025) and an FDA warning document serotonin toxicity when combined with serotonergic drugs
Is harmful at high doses (U-shaped dose-response)
Clinical pharmacology: benefit at low doses reverses to harm at high doses; high doses can themselves cause methemoglobinemia and, in G6PD deficiency, hemolysis
Enhances memory and cognition (nootropic)
Rodriguez et al. 2016 (Radiology): a small human fMRI study found a modest (~7%) memory-retrieval improvement - but at a single ~280 mg dose, roughly 20x a typical 'microdose'
Supports mitochondrial energy production
Rojas et al. 2012 and Gonzalez-Lima 2014: at low concentrations methylene blue acts as an alternative electron carrier supporting cytochrome-oxidase activity and ATP under oxidative stress - mostly cell and animal data
The low 'microdoses' sold are validated by human evidence
The one supportive human study (Rodriguez 2016) used ~280 mg, about 20x the 5-15 mg microdoses most products target; low-dose nootropic efficacy is not established in humans
| Grade | Claimed Benefit | Key Studies | Our Verdict |
|---|---|---|---|
| A | Can cause serotonin syndrome with antidepressants | Ramsay et al. 2007 (Br J Pharmacol): methylene blue potently inhibits MAO-A; case reports and reviews (Zuschlag 2018; McMillan 2025) and an FDA warning document serotonin toxicity when combined with serotonergic drugs | Supported |
| B | Is harmful at high doses (U-shaped dose-response) | Clinical pharmacology: benefit at low doses reverses to harm at high doses; high doses can themselves cause methemoglobinemia and, in G6PD deficiency, hemolysis | Supported |
| C | Enhances memory and cognition (nootropic) | Rodriguez et al. 2016 (Radiology): a small human fMRI study found a modest (~7%) memory-retrieval improvement - but at a single ~280 mg dose, roughly 20x a typical 'microdose' | Early Signal |
| C | Supports mitochondrial energy production | Rojas et al. 2012 and Gonzalez-Lima 2014: at low concentrations methylene blue acts as an alternative electron carrier supporting cytochrome-oxidase activity and ATP under oxidative stress - mostly cell and animal data | Early Signal |
| D | The low 'microdoses' sold are validated by human evidence | The one supportive human study (Rodriguez 2016) used ~280 mg, about 20x the 5-15 mg microdoses most products target; low-dose nootropic efficacy is not established in humans | Conflicted |
How to Choose: Forms, Doses & What Matters
Clinical dose: Nootropic 'microdoses' are ~5-15 mg/day; note the one human memory study used ~280 mg, far above a microdose
Best forms: ONLY USP / pharmaceutical grade with a published COA - never aquarium or industrial grade, pre-measured troches or a 1% liquid for controllable dosing, avoid high-concentration (5-20%) drops that make dosing errors easy
Only if none of the contraindications apply. Use a product that states USP or pharmaceutical grade with a published certificate of analysis. Doses used as a nootropic are low - commonly in the 5-15 mg range - and the safest formats are pre-measured troches or a standard 1% liquid (10 mg per mL), where a few drops is a small dose; high-concentration (5-20%) drops make an accidental overdose far too easy. Start low. Do not chase a bigger effect with a bigger dose, because the benefit reverses to harm as the dose climbs. Expect blue-green urine and possibly a blue tongue - both are harmless. Never take it within roughly two weeks of stopping an antidepressant without medical guidance.
Who Should Take Methylene Blue?
This is only worth considering for someone who is not taking any antidepressant or serotonergic medication, does not have G6PD deficiency, is not pregnant, and understands they are experimenting with a compound whose nootropic benefits are barely studied in humans. If that describes you and you want to try it, the non-negotiables are: buy a product that clearly states USP or pharmaceutical grade and can show a certificate of analysis, start at a low dose (a few milligrams), and treat it as an experiment, not a proven cognitive enhancer.
Who Should Avoid It?
Not for everyone
Side Effects & Safety
Product Scores
5 products scored on dosing accuracy, third-party testing, cost per effective dose, and label transparency.
The Scorecard: 5 Products Compared
Methylene Blue Drops 1% Pharmaceutical Grade (2-pack)
Bluesun
$39.99 ÷ 121 days at 10mg/day (1 serving × 10mg)
Among Amazon-available options, this checks the boxes that actually matter for methylene blue: a stated USP/pharmaceutical grade, a COA claim, and a 1% concentration you can dose low. Confirm the certificate of analysis before use, and only proceed if you are not on antidepressants.
Prices checked 2026-07-06. Cost shown is per clinically effective daily dose, not per pill.
Just Blue (methylene blue troche)
Troscriptions
$27.00 ÷ 27 days at ~2mg/day (0.6 servings × 4mg)
The category's quality reference product, and arguably the cleanest way to dose methylene blue - but it is sold direct from the brand, not on Amazon, so we cannot link it here. If quality documentation is your priority, it is the one to look up directly.
Prices checked 2026-07-06. Cost shown is per clinically effective daily dose, not per pill.
Methylene Blue Drops USP Pharmaceutical Grade 1%
Etta Vita
$24.99 ÷ 60 days at 10mg/day (1 serving × 10mg)
A solid Amazon alternative that states USP grade and purity. As with all of these, the meaningful step is confirming the certificate of analysis, and only using it if you are not on antidepressants.
Prices checked 2026-07-06. Cost shown is per clinically effective daily dose, not per pill.
Methylene Blue 1% Liquid
PureGood
$29.99 ÷ 60 days at 10mg/day (1 serving × 10mg)
It claims third-party testing but does not explicitly state pharmaceutical/USP grade in its listing, which for methylene blue is the one spec you cannot skip. We rank it below the explicitly-USP options until its grade is confirmed by a COA.
Prices checked 2026-07-06. Cost shown is per clinically effective daily dose, not per pill.
Methylene Blue Capsules (stacked formula)
Itharoventis
$34.99 ÷ 44 days at ~14mg/day (1.4 servings × 10mg)
A stacked capsule where the actual methylene blue dose is not disclosed - a problem for a compound where dose control is a safety feature. For methylene blue specifically, a disclosed-dose liquid or troche you can dial low is the safer choice.
Prices checked 2026-07-06. Cost shown is per clinically effective daily dose, not per pill.
Full Comparison
| Category | Methylene Blue Drops 1% Pharmaceutical Grade (2-pack) Bluesun | Just Blue (methylene blue troche) Troscriptions | Methylene Blue Drops USP Pharmaceutical Grade 1% Etta Vita | Methylene Blue 1% Liquid PureGood | Methylene Blue Capsules (stacked formula) Itharoventis |
|---|---|---|---|---|---|
| Brand Score | 80/100Winner | 77/100 | 76/100 | 68/100 | 55/100 |
| Dosing & Form | 20/25 | 22/25Winner | 20/25 | 20/25 | 14/25 |
| Purity | 20/25 | 21/25Winner | 18/25 | 14/25 | 15/25 |
| Value | 20/25Winner | 12/25 | 19/25 | 19/25 | 14/25 |
| Transparency | 20/25 | 22/25Winner | 19/25 | 15/25 | 12/25 |
| Cost/Day | $0.33Winner | $1.00 | $0.42 | $0.50 | $0.80 |
| Dose/Serving | 10mg | 4mg | 10mg | 10mg | 10mg |
| Form | Liquid drops (1%, 10 mg/mL, cobalt glass) | Buccal troche (16 mg, quarterable; USP grade) | Liquid tincture (1%, USP grade) | Liquid drops (1%, amber glass) | Capsule (methylene blue + CoQ10/NAC/PQQ/glycine/vitamin C) |
| Third-Party Tested | ✓ Yes | ✓ Yes | ✓ Yes | ✓ Yes | No |
| Proprietary Blend | No | No | No | No | No |
Frequently Asked Questions
Is it safe to take methylene blue?
Only under specific conditions, and only pharmaceutical-grade product. The two rules that matter most: never combine it with antidepressants or other serotonergic drugs (it is a potent MAO inhibitor and the combination can cause potentially fatal serotonin syndrome, which the FDA has warned about), and use only USP/pharmaceutical grade with a certificate of analysis - never aquarium or industrial dye, which can be contaminated. It is also contraindicated in G6PD deficiency and pregnancy. For someone with none of those issues, low doses appear well tolerated, but the benefits are barely proven.
What is the difference between pharmaceutical-grade and other methylene blue?
It is the same molecule but a completely different product for safety purposes. USP/pharmaceutical grade is manufactured to high purity and tested for heavy metals and contaminants - the only kind fit for human consumption. 'Chemical,' 'lab,' 'reagent,' 'aquarium,' or 'industrial' grade is made to dye fabric or treat fish tanks and can contain heavy-metal and other impurities; it must never be ingested. Look for an explicit USP/pharmaceutical-grade claim and a published certificate of analysis. A 'formaldehyde-free' label is a hint that the grade question is real in this category, since industrial methylene blue can contain formaldehyde.
Can I take methylene blue with my antidepressant?
No. This is a hard contraindication, not a caution. Methylene blue is a potent MAO-A inhibitor, and combining it with SSRIs, SNRIs, other antidepressants, tramadol, triptans, or other serotonergic drugs can cause serotonin syndrome - a potentially fatal reaction that the FDA has specifically warned about. If you take any antidepressant, do not use methylene blue. If you are unsure whether one of your medications is serotonergic, ask a pharmacist before considering it.
Does methylene blue actually work as a nootropic?
The honest answer is that the human evidence is thin. The mechanism is real - at low doses it can support mitochondrial energy production - but the human data for cognitive benefit is essentially one small brain-imaging study that found a modest memory improvement. Crucially, that study used about 280 mg, roughly 20 times the 5-15 mg 'microdose' most supplements are sold at, so it does not actually validate the low doses people take. Treat any nootropic benefit as unproven, not established.
Why does methylene blue turn your tongue and pee blue?
Because it is a blue dye. Blue-green urine and a temporarily blue tongue or mouth are expected, harmless effects and simply reflect that the compound is in your system. They are not a sign of anything wrong. The staining fades as the compound clears. (It can, however, stain surfaces and teeth, which is one reason troches and diluted liquids are more practical than concentrated drops.)
How much methylene blue should I take?
If you use it at all - and only if none of the contraindications apply - nootropic doses are low, commonly in the 5-15 mg range. The dose-response is U-shaped: low doses may help, but higher doses cause harm and can even trigger the blood disorder the drug is used to treat, so more is genuinely worse. A 1% liquid (10 mg/mL) or a pre-measured troche makes low dosing controllable; avoid high-concentration drops where a small measuring error becomes a large dose. Start at the low end and do not escalate.
Related Reading
Sources
- Rodriguez P, et al. Multimodal Randomized Functional MR Imaging of the Effects of Methylene Blue in the Human Brain. Radiology. 2016;281(2):516-526.
- Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol. 2012;96(1):32-45.
- Gonzalez-Lima F, Barksdale BR, Rojas JC. Mitochondrial respiration as a target for neuroprotection and cognitive enhancement. Biochem Pharmacol. 2014;88(4):584-93.
- Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol. 2007;152(6):946-51.
- Zuschlag ZD, et al. Serotonin Toxicity and Urinary Analgesics: A Case Report and Systematic Literature Review of Methylene Blue-Induced Serotonin Syndrome. Psychosomatics. 2018;59(6):539-546.
- US FDA Drug Safety Communication (2011): Serious CNS reactions possible when methylene blue is given to patients taking serotonergic psychiatric medications.
Scores and tiers are our independent opinion, formed by applying a published rubric to label data, third-party certifications, and the research record. They are not statements of objective fact about a product and not a lab test. Where we report a brand-specific fact, it comes from a cited source or a public certification; where verification is missing, we say so rather than assume a result.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any supplement regimen.